A Randomized, Double-blind, Double-dummy, Placebo-controlled, 3x4 Factorial Design Trial to Evaluate Telmisartan 20 and 80 mg Tablets in Combination With Ramipril 1.25, 10, and 20 mg Capsules After Eight Weeks of Treatment in Patients With Stage I or II Hypertension, With an ABPM Sub-study

CompletadoFase 3ClinicalTrials.gov

ID: NCT00281593Tipo: INTERVENTIONALInicio: 1 de abr de 2006

Traducción no disponible, mostrando original

Resumen

To identify dose combinations of telmisartan and ramipril that are more effective in reducing diastolic blood pressure than each of the respective monotherapies in patients with Stage I or II hypertension.

Elegibilidad

Edad mínima: 18 YearsSexo: ALL

Criterios de inclusión

Male and female patients \>=18 years of age with Stage I or II hypertension defined as:
a mean seated cuff diastolic blood pressure \>=95 and \<=119 mmHg Main

Criterios de exclusión

Pregnant
breast-feeding
unwilling to use birth control during the study
secondary hypertension
SBP\>=180 mmHg
DBP\>=120 mmHg
severe renal dysfunction
hepatic insufficiency
stroke within the last 6 months
myocardial infarction, cardiac surgery, percutaneous transluminal coronary angioplasty, unstable angina or coronary artery bypass graft within the past three months
unstable or uncontrolled diabetes
history of angioedema of either of the study drugs, and hypersensitivity to the study drugs.

Intervenciones

drug

Telmisartan

drug

Ramipril

Ubicaciones

1236.1.601 Boehringer Ingelheim Investigational Site

Buenos Aires, Argentina

1236.1.604 Boehringer Ingelheim Investigational Site

Buenos Aires, Argentina

1236.1.605 Boehringer Ingelheim Investigational Site

Buenos Aires, Argentina

1236.1.610

Buenos Aires, Argentina

1236.1.612

Buenos Aires, Argentina

1236.1.619

Capital Federal,Buenos Aires, Argentina

1236.1.608

Capital Federal, Argentina

1236.1.618 Hospital Ramos Mejia

Capital Federal, Argentina

1236.1.615

CordobaCordoba, Argentina

1236.1.611

Corrientes, Argentina

1236.1.603 Boehringer Ingelheim Investigational Site

Córdoba, Argentina

1236.1.606

Córdoba, Argentina

1236.1.613

Córdoba, Argentina

1236.1.614

Córdoba, Argentina

1236.1.624 Instituto de Investigaciones Clínicas

Mar del Plata, Argentina

1236.1.609

Presidente Derqui, Argentina

1236.1.620 DIM - Clinica Privada

Ramos Mejía, Argentina

1236.1.622 Hospital San Bernardo

Salta, Argentina

1236.1.621 Clinica del Torax y Especialidades

Santa Fe, Argentina

1236.1.602 Boehringer Ingelheim Investigational Site

Villa Carlos Paz, Argentina

1236.1.616

Zárate, Argentina

Patrocinadores

PrincipalBoehringer Ingelheim

Aviso: La información de este ensayo proviene de fuentes públicas y tiene carácter exclusivamente informativo. No constituye asesoramiento médico, regulatorio ni de ningún otro tipo. Las traducciones son automatizadas y no poseen validez oficial. Consultá siempre con un profesional de la salud. Ver Términos de Uso.

A Randomized, Double-blind, Double-dummy, Placebo-control... | EligiMed